Too Late To Buy Denbury Resources Inc (NYSE: DNR)?


Denbury Resources Inc (NYSE: DNR), an energy company with a market capitalization of $1.8 billion, saw its share price increase by 82.9% over the prior three months. As a small-cap stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. Is there still an opportunity here to buy? Let’s examine Denbury’s valuation and outlook in more detail to determine if there’s still a bargain opportunity.

Is Denbury Still Cheap?

According to my valuation models, the stock is currently overvalued by approximately -16.7%, trading at $4.21 compared to its intrinsic value of $3.51. Not the best news for investors looking to buy!

Denbury Resources Inc Valuation Detail
Analysis Model Fair Value Upside (Downside)
5-yr DCF Revenue Exit $2.80 -33.5%
Peer Revenue Multiples $5.95 41.4%
10-yr DCF EBITDA Exit $1.33 -68.5%
5-yr DCF EBITDA Exit $4.40 4.5%
Peer EBITDA Multiples $3.06 -27.4%
Average $3.51 -16.7%

Click on any of the analyses above to view the latest model with real-time data.

However, will there be another opportunity to buy low in the future? Given that Denbury’s stock is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) could mean the price can sink lower, giving investors another chance to buy in the future. This is based on its beta of 4.13, which is a good indicator for share price volatility.

What Does The Future Of Denbury Look Like?

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company’s future expectations.

Denbury projected revenue chartsource: data explorer

With Denbury’s relatively muted top-line growth of 3.9% expected over the next five years on average, growth doesn’t seem like a key catalyst for a buying decision, at least in the short to medium-term.

How This Impacts You

Many investors separate stocks into value and growth categories based on quantitative metrics. However, one of the most famous investors in the world views this as foolish. In Warren Buffett’s 1992 letter to Berkshire Hathaway shareholders, Buffett touches upon a subject at odds with much of the investment industry:

“Most analysts feel they must choose between two approaches customarily thought to be in opposition: ‘value’ and ‘growth.’ Indeed, many investment professionals see any mixing of the two terms as a form of intellectual cross-dressing. We view that as fuzzy thinking… In our opinion, the two approaches are joined at the hip: Growth is always a component in the calculation of value.”

While investors tend to categorize stocks into value and growth, some of the most successful investors view growth as simply one component of a company’s value.

Unfortunately for shareholders, Denbury’s future growth is relatively low and it appears the stock is now trading above its intrinsic value. Therefore, it may be a good time to begin reducing your position in the company. However, there are also other factors to consider that could explain the current overvaluation.

But before making an investment decision, I recommend you continue to research Denbury to get a more comprehensive view of the company by looking at:

Risk Metrics: how much interest coverage does Denbury Resources Inc have? This is a ratio used to assess a firm’s ability to pay interest expenses based on operating profits (EBIT). View the company’s interest coverage here.

Valuation Metrics: what is Denbury Resources Inc’s short ratio and how does it compare to its publicly traded peers? It represents the percentage of total shares outstanding that is being shorted. View the short ratio here.

Efficiency Metrics: fixed asset turnover is calculated by dividing revenue by average fixed assets. View Denbury Resources Inc’s fixed asset turnover here.

As of this writing, I did not hold a position in any of the aforementioned securities and this is not a buy or sell recommendation on any security mentioned.

Expertise: financial technology, analyzing market trends. Brian is a founder at, where he’s focused on building tools that make it faster and easier for investors to research stock fundamentals. Brian’s background is in physics & computer science and previously worked as a software engineer at GE Healthcare. He enjoys applying his expertise in technology to help find market trends that impact investors. Brian can be reached at or at +1 (516) 778-6257.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.